Silo Pharma receives US patent for stress-induced affective disorder prophylactics

Silo Pharma, Inc.

USPTO granted Patent No. 12,239,614 for exclusively licensed Columbia University technology.
Patent titled 'Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females'.
Patent covers prophylactic treatment for stress-induced affective disorders specifically in females.
License is exclusive from Columbia University; patent application originally filed as 17/954864.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.